QuantiGene plex represents a promising diagnostic tool for cell-of-origin subtyping of diffuse large B-cell lymphoma

Journal of Molecular Diagnostics

Volumn 17, Issue 4, 2015, Pages 402-411

  Hall, John S ^a   Usher, Suzanne ^a   Byers, Richard J ^a   Higgins, Rebekah C ^a   Memon, Danish ^b   Radford, John A ^a,c   Linton, Kim M ^a,c  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c CHRISTIE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FORMALDEHYDE; PARAFFIN;

AREA UNDER THE CURVE; ARTICLE; CANCER CLASSIFICATION; CLASSIFIER; CLINICAL ARTICLE; COMPUTER MODEL; COST BENEFIT ANALYSIS; DIAGNOSTIC PROCEDURE; DNA MICROARRAY; GENE EXPRESSION PROFILING; HUMAN; HUMAN TISSUE; LARGE CELL LYMPHOMA; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PROTEIN MICROARRAY; QUANTIGENE PLEX; QUANTITATIVE ANALYSIS; TISSUE SECTION; VALIDATION STUDY; ANTIBODY SPECIFICITY; BAYES THEOREM; CLASSIFICATION; COHORT ANALYSIS; GENE EXPRESSION REGULATION; GENETICS; MOLECULAR DIAGNOSIS; PATHOLOGY; PROCEDURES; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION;

BAYES THEOREM; COHORT STUDIES; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LYMPHOMA, LARGE B-CELL, DIFFUSE; MOLECULAR DIAGNOSTIC TECHNIQUES; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; ORGAN SPECIFICITY; PARAFFIN EMBEDDING; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84931335667     PISSN: 15251578     EISSN: 19437811     Source Type: Journal    
DOI: 10.1016/j.jmoldx.2015.03.010     Document Type: Article

References (51)

1. G. Lenz, G. Wright, S.S. Dave, W. Xiao, J. Powell, and H. Zhao Stromal gene signatures in large-B-cell lymphomas N Engl J Med 359 2008 2313 2323
2. A.A. Alizadeh, M.B. Eisen, R.E. Davis, C. Ma, I.S. Lossos, A. Rosenwald, J.C. Boldrick, H. Sabet, T. Tran, X. Yu, J.I. Powell, L. Yang, G.E. Marti, T. Moore, J. Hudson Jr., L. Lu, D.B. Lewis, R. Tibshirani, G. Sherlock, W.C. Chan, T.C. Greiner, D.D. Weisenburger, J.O. Armitage, R. Warnke, R. Levy, W. Wilson, M.R. Grever, J.C. Byrd, D. Botstein, P.O. Brown, and L.M. Staudt Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling Nature 403 2000 503 511
3. A. Rosenwald, G. Wright, W.C. Chan, J.M. Connors, E. Campo, and R.I. Fisher The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma N Engl J Med 346 2002 1937 1947
4. G. Lenz, G.W. Wright, N.C. Emre, H. Kohlhammer, S.S. Dave, R.E. Davis, S. Carty, L.T. Lam, A.L. Shaffer, W. Xiao, J. Powell, A. Rosenwald, G. Ott, H.K. Muller-Hermelink, R.D. Gascoyne, J.M. Connors, E. Campo, E.S. Jaffe, J. Delabie, E.B. Smeland, L.M. Rimsza, R.I. Fisher, D.D. Weisenburger, W.C. Chan, and L.M. Staudt Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways Proc Natl Acad Sci U S A 105 2008 13520 13525
5. R.E. Davis, K.D. Brown, U. Siebenlist, and L.M. Staudt Constitutive nuclear factor kappaB activity is required for survival of activated B cell-like diffuse large B cell lymphoma cells J Exp Med 194 2001 1861 1874
6. R.E. Davis, V.N. Ngo, G. Lenz, P. Tolar, R.M. Young, and P.B. Romesser Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma Nature 463 2010 88 92
7. A. Pavan, M. Spina, V. Canzonieri, S. Sansonno, G. Toffoli, and V. De Re Recent prognostic factors in diffuse large B-cell lymphoma indicate NF-kappaB pathway as a target for new therapeutic strategies Leuk Lymphoma 49 2008 2048 2058
8. K.H. Lim, Y. Yang, and L.M. Staudt Pathogenetic importance and therapeutic implications of NF-kappaB in lymphoid malignancies Immunol Rev 246 2012 359 378
9. A. Aalipour, and R.H. Advani Bruton tyrosine kinase inhibitors: a promising novel targeted treatment for B cell lymphomas Br J Haematol 163 2013 436 443
10. C.U. Niemann, and A. Wiestner B-cell receptor signaling as a driver of lymphoma development and evolution Semin Cancer Biol 23 2013 410 421
11. F.J. Hernandez-Ilizaliturri, G. Deeb, P.L. Zinzani, S.A. Pileri, F. Malik, W.R. Macon, A. Goy, T.E. Witzig, and M.S. Czuczman Higher response to lenalidomide in relapsed/refractory diffuse large B-cell lymphoma in nongerminal center B-cell-like than in germinal center B-cell-like phenotype Cancer 117 2011 5058 5066
12. J. Ruan, P. Martin, R.R. Furman, S.M. Lee, K. Cheung, J.M. Vose, A. Lacasce, J. Morrison, R. Elstrom, S. Ely, A. Chadburn, E. Cesarman, M. Coleman, and J.P. Leonard Bortezomib plus CHOP-rituximab for previously untreated diffuse large B-cell lymphoma and mantle cell lymphoma J Clin Oncol 29 2011 690 697
13. X. Zheng, N. Ding, Y. Song, L. Feng, and J. Zhu Different sensitivity of germinal center B cell-like diffuse large B cell lymphoma cells towards ibrutinib treatment Cancer Cell Int 14 2014 32
14. K. Dunleavy, S. Pittaluga, M.S. Czuczman, S.S. Dave, G. Wright, N. Grant, M. Shovlin, E.S. Jaffe, J.E. Janik, L.M. Staudt, and W.H. Wilson Differential efficacy of bortezomib plus chemotherapy within molecular subtypes of diffuse large B-cell lymphoma Blood 113 2009 6069 6076
15. J.E. Amengual, S. Clark-Garvey, M. Kalac, L. Scotto, E. Marchi, E. Neylon, P. Johannet, Y. Wei, J. Zain, and O.A. O'connor Sirtuin and pan-class I/II deacetylase (DAC) inhibition is synergistic in preclinical models and clinical studies of lymphoma Blood 122 2013 2104 2113
16. J.J. Steinhardt, and R.B. Gartenhaus Promising personalized therapeutic options for diffuse large B-cell lymphoma subtypes with oncogene addictions Clin Cancer Res 18 2012 4538 4548
17. C.P. Hans, D.D. Weisenburger, T.C. Greiner, R.D. Gascoyne, J. Delabie, G. Ott, H.K. Muller-Hermelink, E. Campo, R.M. Braziel, E.S. Jaffe, Z. Pan, P. Farinha, L.M. Smith, B. Falini, A.H. Banham, A. Rosenwald, L.M. Staudt, J.M. Connors, J.O. Armitage, and W.C. Chan Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray Blood 103 2004 275 282
18. W.W. Choi, D.D. Weisenburger, T.C. Greiner, M.A. Piris, A.H. Banham, J. Delabie, R.M. Braziel, H. Geng, J. Iqbal, G. Lenz, J.M. Vose, C.P. Hans, K. Fu, L.M. Smith, M. Li, Z. Liu, R.D. Gascoyne, A. Rosenwald, G. Ott, L.M. Rimsza, E. Campo, E.S. Jaffe, D.L. Jaye, L.M. Staudt, and W.C. Chan A new immunostain algorithm classifies diffuse large B-cell lymphoma into molecular subtypes with high accuracy Clin Cancer Res 15 2009 5494 5502
19. P.N. Meyer, K. Fu, T.C. Greiner, L.M. Smith, J. Delabie, R.D. Gascoyne, G. Ott, A. Rosenwald, R.M. Braziel, E. Campo, J.M. Vose, G. Lenz, L.M. Staudt, W.C. Chan, and D.D. Weisenburger Immunohistochemical methods for predicting cell of origin and survival in patients with diffuse large B-cell lymphoma treated with rituximab J Clin Oncol 29 2011 200 207
20. A.M. Perry, T.M. Cardesa-Salzmann, P.N. Meyer, L. Colomo, L.M. Smith, K. Fu, T.C. Greiner, J. Delabie, R.D. Gascoyne, L. Rimsza, E.S. Jaffe, G. Ott, A. Rosenwald, R.M. Braziel, R. Tubbs, J.R. Cook, L.M. Staudt, J.M. Connors, L.H. Sehn, J.M. Vose, A. Lopez-Guillermo, E. Campo, W.C. Chan, and D.D. Weisenburger A new biologic prognostic model based on immunohistochemistry predicts survival in patients with diffuse large B-cell lymphoma Blood 120 2012 2290 2296
21. J.J. Muris, C.J. Meijer, W. Vos, J.H. van Krieken, N.M. Jiwa, G.J. Ossenkoppele, and J.J. Oudejans Immunohistochemical profiling based on Bcl-2, CD10 and MUM1 expression improves risk stratification in patients with primary nodal diffuse large B cell lymphoma J Pathol 208 2006 714 723
22. D. de Jong, A. Rosenwald, M. Chhanabhai, P. Gaulard, W. Klapper, A. Lee, B. Sander, C. Thorns, E. Campo, T. Molina, A. Norton, A. Hagenbeek, S. Horning, A. Lister, J. Raemaekers, R.D. Gascoyne, G. Salles, E. Weller Lunenburg Lymphoma Biomarker Consortium Immunohistochemical prognostic markers in diffuse large B-cell lymphoma: validation of tissue microarray as a prerequisite for broad clinical applications: a study from the Lunenburg Lymphoma Biomarker Consortium J Clin Oncol 25 2007 805 812
23. J.J. Anderson, S. Fordham, L. Overman, H. Dignum, K. Wood, S.J. Proctor, S. Crosier, B. Angus, R.E. Culpin, and T. Mainou-Fowler Immunophenotyping of diffuse large B-cell lymphoma (DLBCL) defines multiple sub-groups of germinal centre-like tumours displaying different survival characteristics Int J Oncol 35 2009 961 971
24. L.M. Morton, J.R. Cerhan, P. Hartge, M.A. Vasef, V.T. Neppalli, Y. Natkunam, A. Dogan, B.J. Dave, S. Jain, R. Levy, I.S. Lossos, W. Cozen, S. Davis, M.J. Schenk, M.J. Maurer, C.F. Lynch, N. Rothman, N. Chatterjee, K. Yu, L.M. Staudt, D.D. Weisenburger, and S.S. Wang Immunostaining to identify molecular subtypes of diffuse large B-cell lymphoma in a population-based epidemiologic study in the pre-rituximab era Int J Mol Epidemiol Genet 2 2011 245 252
25. N. Rayman, K.H. Lam, B. van der Holt, C. Koss, D. Veldhuizen, L.M. Budel, A.H. Mulder, L.F. Verdonck, R. Delwel, J.D. de, G.W. van Imhoff, and P. Sonneveld Prognostic relevance of immunohistochemical subclassification of diffuse large B-cell lymphoma in two prospective phase III clinical trials Clin Lymphoma Myeloma Leuk 11 2011 23 32
26. G.J. Tsongalis Branched DNA technology in molecular diagnostics Am J Clin Pathol 126 2006 448 453
27. D.G. Murphy, P. Gonin, and M. Fauvel Reproducibility and performance of the second-generation branched-DNA assay in routine quantification of human immunodeficiency virus type 1 RNA in plasma J Clin Microbiol 37 1999 812 814
28. C.A. Gleaves, J. Welle, M. Campbell, T. Elbeik, V. Ng, P.E. Taylor, K. Kuramoto, S. Aceituno, E. Lewalski, B. Joppa, L. Sawyer, C. Schaper, D. McNairn, and T. Quinn Multicenter evaluation of the Bayer VERSANT HIV-1 RNA 3.0 assay: analytical and clinical performance J Clin Virol 25 2002 205 216
29. E. Arikawa, Y. Sun, J. Wang, Q. Zhou, B. Ning, S.L. Dial, L. Guo, and J. Yang Cross-platform comparison of SYBR Green real-time PCR with TaqMan PCR, microarrays and other gene expression measurement technologies evaluated in the MicroArray Quality Control (MAQC) study BMC Genomics 9 2008 328
30. D. Trabzuni, M. Ryten, R. Walker, C. Smith, S. Imran, A. Ramasamy, M.E. Weale, and J. Hardy Quality control parameters on a large dataset of regionally dissected human control brains for whole genome expression studies J Neurochem 119 2011 275 282
31. L.K. Ching, F. Mompoint, J.A. Guderian, A. Picone, I.M. Orme, R.N. Coler, S.G. Reed, and S.L. Baldwin Transcriptional profiling of TLR-4/7/8-stimulated guinea pig splenocytes and whole blood by bDNA assay J Immunol Methods 373 2011 54 62
32. J.S. Hall, H.S. Leong, L.S. Armenoult, G.E. Newton, H.R. Valentine, J.J. Irlam, C. Moller-Levet, K.A. Sikand, S.D. Pepper, C.J. Miller, and C.M. West Exon-array profiling unlocks clinically and biologically relevant gene signatures from formalin-fixed paraffin-embedded tumour samples Br J Cancer 104 2011 971 981
33. H.W. Yim, B.J. Song, S.S. Jung, H.-J. Kim, Y.-J. Choi, K.-Y. Lee, and A. Lee Branched-chain assay for ER, PR, and HER2 RNA levels is a useful adjunct in the evaluation of ER, PR, and HER2 in breast cancer J Breast Cancer 13 2010 267 274
34. K. Linton, C. Howarth, M. Wappett, G. Newton, C. Lachel, J. Iqbal, S. Pepper, R. Byers, W.J. Chan, and J. Radford Microarray gene expression analysis of fixed archival tissue permits molecular classification and identification of potential therapeutic targets in diffuse large B-cell lymphoma J Mol Diagn 14 2012 223 232
35. P.M. Williams, R. Li, N.A. Johnson, G. Wright, J.D. Heath, and R.D. Gascoyne A novel method of amplification of FFPET-derived RNA enables accurate disease classification with microarrays J Mol Diagn 12 2010 680 686
36. R.J. Byers, E. Sakhinia, P. Joseph, C. Glennie, J.A. Hoyland, L.P. Menasce, J.A. Radford, and T. Illidge Clinical quantitation of immune signature in follicular lymphoma by RT-PCR-based gene expression profiling Blood 111 2008 4764 4770
37. R. Byers, J. Roebuck, E. Sakhinia, and J. Hoyland PolyA PCR amplification of cDNA from RNA extracted from formalin-fixed paraffin-embedded tissue Diagn Mol Pathol 13 2004 144 150
38. K.J. Livak, and T.D. Schmittgen Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method Methods 25 2001 402 408
39. G. Wright, B. Tan, A. Rosenwald, E.H. Hurt, A. Wiestner, and L.M. Staudt A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma Proc Natl Acad Sci U S A 100 2003 9991 9996
40. A. Tanney, and R.D. Kennedy Developing mRNA-based biomarkers from formalin-fixed paraffin-embedded tissue Per Med 7 2010 205 211
41. R.D. Kennedy, M. Bylesjo, P. Kerr, T. Davison, J.M. Black, and E.W. Kay Development and independent validation of a prognostic assay for stage II colon cancer using formalin-fixed paraffin-embedded tissue J Clin Oncol 29 2011 4620 4626
42. S.M. Farragher, A. Tanney, R.D. Kennedy, and H.D. Paul RNA expression analysis from formalin fixed paraffin embedded tissues Histochem Cell Biol 130 2008 435 445
43. S.L. Barrans, S. Crouch, M.A. Care, L. Worrillow, A. Smith, R. Patmore, D.R. Westhead, R. Tooze, E. Roman, and A.S. Jack Whole genome expression profiling based on paraffin embedded tissue can be used to classify diffuse large B-cell lymphoma and predict clinical outcome Br J Haematol 159 2012 441 453
44. K. Linton, Y. Hey, S. Dibben, C. Miller, A. Freemont, J. Radford, and S. Pepper Methods comparison for high-resolution transcriptional analysis of archival material on Affymetrix Plus 2.0 and Exon 1.0 microarrays Biotechniques 47 2009 587 596
45. K.M. Linton, Y. Hey, E. Saunders, M. Jeziorska, J. Denton, C.L. Wilson, R. Swindell, S. Dibben, C.J. Miller, S.D. Pepper, J.A. Radford, and A.J. Freemont Acquisition of biologically relevant gene expression data by Affymetrix microarray analysis of archival formalin-fixed paraffin-embedded tumours Br J Cancer 98 2008 1403 1414
46. R.D. Canales, Y. Luo, J.C. Willey, B. Austermiller, C.C. Barbacioru, C. Boysen, K. Hunkapiller, R.V. Jensen, C.R. Knight, K.Y. Lee, Y. Ma, B. Maqsodi, A. Papallo, E.H. Peters, K. Poulter, P.L. Ruppel, R.R. Samaha, L. Shi, W. Yang, L. Zhang, and F.M. Goodsaid Evaluation of DNA microarray results with quantitative gene expression platforms Nat Biotechnol 24 2006 1115 1122
47. I. Koch, J. Slotta-Huspenina, R. Hollweck, N. Anastasov, H. Hofler, L. Quintanilla-Martinez, and F. Fend Real-time quantitative RT-PCR shows variable, assay-dependent sensitivity to formalin fixation: implications for direct comparison of transcript levels in paraffin-embedded tissues Diagn Mol Pathol 15 2006 149 156
48. M.T. Gilbert, T. Haselkorn, M. Bunce, J.J. Sanchez, S.B. Lucas, L.D. Jewell, M.E. Van, and M. Worobey The isolation of nucleic acids from fixed, paraffin-embedded tissues: which methods are useful when? PLoS One 2 2007 e537
49. D.C. Metzger, J.A. Luckenbach, J.T. Dickey, and B.R. Beckman Development of a multiplex gene expression assay for components of the endocrine growth axis in coho salmon Gen Comp Endocrinol 189 2013 134 140
50. B.S. Knudsen, A.N. Allen, D.F. McLerran, R.L. Vessella, J. Karademos, J.E. Davies, B. Maqsodi, G.K. McMaster, and A.R. Kristal Evaluation of the branched-chain DNA assay for measurement of RNA in formalin-fixed tissues J Mol Diagn 10 2008 169 176
51. D.W. Scott, G.W. Wright, P.M. Williams, C.J. Lih, W. Walsh, E.S. Jaffe, A. Rosenwald, E. Campo, W.C. Chan, J.M. Connors, E.B. Smeland, A. Mottok, R.M. Braziel, G. Ott, J. Delabie, R.R. Tubbs, J.R. Cook, D.D. Weisenburger, T.C. Greiner, B.J. Glinsmann-Gibson, K. Fu, L.M. Staudt, R.D. Gascoyne, and L.M. Rimsza Determining cell-of-origin subtypes of diffuse large B-cell lymphoma using gene expression in formalin-fixed paraffin-embedded tissue Blood 123 2014 1214 1217